Picture of InVitae logo

NVTAQ InVitae Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for InVitae, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-129-242-602-379-3,106
Depreciation
Deferred Taxes
Non-Cash Items30.290.4361-1972,542
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.758.7716-27.6-25.3
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-92.2-145-299-560-493
Capital Expenditures-5.97-20-22.9-54.7-53.3
Purchase of Fixed Assets
Other Investing Cash Flow Items41.7-260-378-149-121
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities35.8-280-401-204-175
Financing Cash Flow Items-4.61-10.600
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1574656731,5661.76
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash10139.4-26.1802-666